Welcome to our Life Sciences and the Law newsletter
This month we point you towards a number of recent articles we’ve produced, including important points that companies need to consider in relation to investment and funding; changes to NHS procurement guidelines to include consideration of net zero carbon targets and social value and commentary on the DHSC review into more effective analysis of NHS historical data.
We also share client news on the recent acquisition of Parity Medical by US manufacturer Touchpoint, and an investment into life sciences marketing agency ramarketing by private equity firm NorthEdge.
Our Q&A sees JuvLife CEO Colin Watts in the chair, providing an insight into his company’s research and upcoming webinar on the science of ketones as an aid to achieving healthy older age.
And finally, in our Meet the Team spot we introduce you to Caroline Lorkin, associate in our Life Sciences/Health team, whom some of you will already have met at Arab Health in January and whose particular focus is on the provision of transactional, commercial, and contractual advice to private healthcare providers, NHS organisations and healthtech start-ups.
For further information, please contact:
Michael Corcoran, Partner, Hill Dickinson
michael.corcoran@hilldickinson.com
